Incidence and predictors for abnormal liver function during direct-acting antiviral agents in chronic hepatitis C patients

Abrupt alanine aminotransferase (ALT) elevation during direct-acting antiviral agents (DAA) treatment is an uncommon but noticeable adverse event in chronic hepatitis C (CHC) patients, which may lead to early termination of treatment. This study aims to investigate the incidence, outcome and predict...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yen-Chun, Jeng, Wen-Juei, Cheng, Ya-Ting, Hsieh, Yi-Chung, Teng, Wei, Chen, Yi-Cheng, Lin, Chun-Yen, Chien, Rong-Nan, Sheen, I-Shyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
4500
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7489670/
https://www.ncbi.nlm.nih.gov/pubmed/32925725
http://dx.doi.org/10.1097/MD.0000000000021898

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7489670/
https://www.ncbi.nlm.nih.gov/pubmed/32925725
http://dx.doi.org/10.1097/MD.0000000000021898

Ejemplares similares